Data presented at ATS 2025 showed that lung improvement in paediatric cystic fibrosis (CF) patients receiving ETI therapy is ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Skye has entered a partnership with Arecor aimed at developing a higher formulation of the former’s obesity candidate, ...

Novotech is a winner in the Diversity, Research and Development, and Marketing categories in the 2025 Pharmaceutical ...

The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vösendorf, Austria on ...

The agreement will see international initiatives to fight the next pandemic, but funding remains the weak link.

The Japanese MHLW has granted approval for the use of GSK’s Blenrep (belantamab mafodotin) combinations for MM.

An ATS 2025 session presented data showing that anti–IL-5 biologics significantly cut exacerbations in coexisting asthma and ...

The published long-term data suggests that the treatment could maintain its dominant position in the CF market.

Pfizer has signed a worldwide licensing agreement, excluding China, with biopharmaceutical company 3SBio for SSGJ-707.

The sale brings attention back to privacy concerns as Regeneron now controls genetic data from millions of 23andMe customers.

Apnimed will be waiting for the readout from a second Phase III trial before it approaches the FDA with an NDA for the sleep ...